Skip to main navigation
About
About
Contact Us
Pipeline
Pipeline
Sirexatamab (DKN-01) Programs
Gastric Cancer
Colorectal Cancer
Endometrial Cancer
Prostate Cancer
Lung Cancer
FL-301(NBL-015) Program
FL-501 Program
Science
Science
DKK1
Sirexatamab (DKN-01)
Claudin18.2
GDF15
Patients
Patients
Expanded Access
Careers
Investors
Investors
Stock Information
News Releases
Presentations & Events
Financial Information
Corporate Governance
Information Request
Contact
Us
Contact Us
Argot Partners
+1-212-600-1902
leap@argotpartners.com
Print Page
Email Alerts
Contact Us
